JAMES C YAO to Mechanistic Target of Rapamycin Complex 2
This is a "connection" page, showing publications JAMES C YAO has written about Mechanistic Target of Rapamycin Complex 2.
Connection Strength
0.037
-
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Na?ve Advanced Pancreatic Neuroendocrine Tumors. Oncologist. 2018 07; 23(7):766-e90.
Score: 0.037